Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood Cancer Journal

Topics

Biology

Cancer Oncology

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.1038/s41408-024-01105-8

License

CC-BY-NC-ND